Paydirt
TP
Insider

Third Rock Ventures V, L.P.

10% owner

Third Rock Ventures V, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $5.4M of RAPP (133,618 sh × $40.24, as filed), executed May 11.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.1M
shares × price, as filed
Last traded
May 26
Filed May 28

Median ADV $17.2M across their filed names

Open performance
Volume by month
$6.1M$3.1M$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · sells $6.1M
Buys $0 Sells $6.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
RAPP Rapport Therapeutics, Inc. RAPP · 0 buys · 2 sells 2 filings
Recent filings
RAPPSALE Rapport Therapeutics, Inc. View filing → $744K
18,572 sh × $40.05
Exec May 26
Filed May 28 · 5:30 PM ET
RAPPSALE Rapport Therapeutics, Inc. View filing → $5.4M
133,618 sh × $40.24
Exec May 11
Filed May 13 · 5:30 PM ET